© 1992 Oxford University Press
research-article |
Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986
Toxicology Research Laboratories, Lilly Research Laboratories, a Division of Eli Lilly and Company P0 Box 708, Greenfield, IN 46140, USA
In order to better understand the molecular events in murine hepatocarcinogenesis, the frequency and types of mutations in the murine H-ras proto-oncogene isolated from 184 independent, spontaneously occurring hepatic lesions were determined. Hepatocellular foci, hyperplasias, adenomas and carcinomas were obtained from archival samples of control male (134 samples) and female (50 samples) B6C3F1 mice used in oncogenicity studies that were conducted at Lilly Research Laboratories from 1979 to 1986. The 61st codon region of the H-ras oncogene from these sections amplified using the polymerase chain reaction. Mutation frequencies were determined by restriction fragment length polymorphism analysis. The types of mutations were characterized by allele-specific oligonucleotide hybridization and confirmed by DNA sequencing. Forty-two per cent of the carcinomas, 44% of the adenomas, 42% of the hyperplasias and 29% the foci contained mutations at the 61 codon. The mutation spectra for the carcinomas, adenomas and hyperplasias consisted of mostly CAAAAA transverslons, followed by CAACGA transitions, followed by CAACTA transversions. These results demonstrate that: (i) the frequency of spontaneous mutations in the H-ras 61st codon is equivalent in murine hyperplasias, adenomas and carcinomas, and (ii) sex was not a determining factor in either the mutation frequency or mutation spectrum for the spontaneous lesions. If these lesions represent successive stages in the carcinogenic process, then these results suggest that mutations In the 61st codon of H-ras are early events in spontaneous murine hepatocarcinogenesis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors Toxicol. Sci., April 1, 2006; 90(2): 400 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Thomas and J. L. Abbruzzese Opportunities for Targeted Therapies in Hepatocellular Carcinoma J. Clin. Oncol., November 1, 2005; 23(31): 8093 - 8108. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-H. Lin, J. Nakamura, S. Yamaguchi, P. B. Upton, D. K. La, and J. A. Swenberg Oxidative damage and direct adducts in calf thymus DNA induced by the pentachlorophenol metabolites, tetrachlorohydroquinone and tetrachloro-1,4-benzoquinone Carcinogenesis, April 1, 2001; 22(4): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Culp, A. R. Warbritton, B. A. Smith, E. E. Li, and F. A. Beland DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene Carcinogenesis, July 1, 2000; 21(7): 1433 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ogawa, M. Osanai, M. Obata, K. Ishizaki, and K. Kamiya Gain of chromosomes 15 and 19 is frequent in both mouse hepatocellular carcinoma cell lines and primary tumors, but loss of chromosomes 4 and 12 is detected only in the cell lines Carcinogenesis, November 1, 1999; 20(11): 2083 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-m. Hayashi, I. Mori, T. Nonoyama, and K. Mitsumori Point Mutations of the c-H-ras Gene in Spontaneous Liver Tumors of Transgenic Mice Carrying the Human c-H-ras Gene Toxicol Pathol, July 1, 1998; 26(4): 556 - 561. [Abstract] [PDF] |
||||
![]() |
D. E. Malarkey and R. R. Maronpot Polymerase Chain Reaction and In Situ Hybridization: Applications in Toxicological Pathology Toxicol Pathol, January 1, 1996; 24(1): 13 - 23. [Abstract] [PDF] |
||||



